S

Sarepta Therapeutics
D

SRPT

62.490
USD
0.61
(0.99%)
مغلق
حجم التداول
0
الربح لكل سهم
8
العائد الربحي
-
P/E
25
حجم السوق
6,063,534,242
أصول ذات صلة
AMGN
AMGN
-1.12
(-0.37%)
305.62 USD
BIIB
BIIB
-0.710
(-0.54%)
131.320 USD
BMRN
BMRN
0.380
(0.56%)
68.300 USD
GILD
GILD
0.670
(0.60%)
111.930 USD
INCY
INCY
1.415
(2.32%)
62.320 USD
I
IONS
1.455
(5.34%)
28.715 USD
R
RCKT
0.49000
(8.44%)
6.29500 USD
REGN
REGN
8.56
(1.39%)
625.24 USD
VRTX
VRTX
-1.36
(-0.28%)
483.38 USD
المزيد
الأخبار المقالات

العنوان: Sarepta Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.